序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
1 | 2204226-02-6 | Thalidomide-O-amido-PEG-C2-NH2 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
2 | 2376990-31-5 | Thalidomide-O-amido-C6-NH2 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
3 | | Thalidomide-O-amido-C8-NH2 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
4 | 501081-38-5 | FGI-106 |
≥98% | | 询价 |
5 | 1037-50-9 | Sulfadimethoxine sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
6 | 1069622-60-1 | MCHR1 antagonist 3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
7 | 925213-80-5 | GSK269962A 3HCl |
≥98% | | 询价 |
8 | 392711-19-2 | Rapamycin-d3 |
≥98% | | 询价 |
9 | 1314021-57-2 | ARQ 069 |
≥98% | 50mg, 100mg, 250mg | 询价 |
10 | 1426174-41-5 | Ezetimibe phenoxy glucuronide-D4 |
≥98% | | 询价 |
11 | 2341796-76-5 | (S,R,S)-AHPC-PEG2-NH2 diHCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
12 | 59450-89-4 | Calcimycin hemicalcium salt |
≥98% | | 询价 |
13 | 2102101-72-2 | IPN-60090 diHCl |
≥98% | | 询价 |
14 | 1783987-80-3 | CYM5442 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
15 | 848035-21-2 | Compound 48/80 triHCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
16 | 2095432-39-4 | MRT67307 HCl |
≥98% | | 询价 |
17 | 140909-80-4 | Serrawettin W2 |
≥98% | | 询价 |
18 | 56-41-7 | alanine |
≥98% | | 询价 |
19 | 1254205-52-1 | RQ-00203078 |
≥98% | | 询价 |
20 | 706809-20-3 | Alalevonadifloxacin |
≥98% | | 询价 |
21 | 61-40-5 | AQ 1989 |
≥98% | | 询价 |
22 | 911378-38-6 | RBI-257 Maleate |
≥98% | | 询价 |
23 | 117-89-5 | Trifluoperazine(TFP SKF5019) |
≥98% | | 询价 |
24 | 5352-53-4 | BPH-1358 |
≥98% | | 询价 |
25 | 135410-20-7 | Acetamiprid |
≥98% | | 询价 |
26 | 37517-28-5 | Amikacin free base |
≥98% | | 询价 |
27 | 4966-13-6 | Lambertianic acid |
≥98% | | 询价 |
28 | 199396-76-4 | Asoprisnil |
≥98% | | 询价 |
29 | 124-76-5 | Isoborneol |
≥98% | | 询价 |
30 | 203737-94-4 | PST2774 oxalate |
≥98% | | 询价 |
31 | 920113-03-7 | Riviciclib HCl(P276-00) |
≥98% | | 询价 |
32 | 99260-65-8 | Saquayamycin |
≥98% | | 询价 |
33 | 16844-71-6 | Epifriedelanol |
≥98% | | 询价 |
34 | 81489-64-7 | Ascorbyl nicotinate |
≥98% | | 询价 |
35 | 124495-31-4 | 8-Chloro-4-(2-chloro-4-fluorophenoxy)quinoline |
≥98% | | 询价 |
36 | 132-69-4 | Benzydamine hydrochloride |
≥98% | | 询价 |
37 | 24390-12-3 | Fantridone HCl |
≥98% | | 询价 |
38 | 910562-18-4 | Aganepag |
≥98% | | 询价 |
39 | | DREADD agonist 21 diHCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
40 | 84176-65-8 | Antimalarial agent 1 |
≥98% | | 询价 |
41 | 2140301-98-8 | PF-04634817 succinate |
≥98% | 50mg, 100mg, 250mg | 询价 |
42 | 137433-23-9 | (R)-Hydroxychloroquine |
≥98% | | 询价 |
43 | 2093386-51-5 | Thalidomide-NH-C6-NH2 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
44 | 137433-24-0 | (S)-Hydroxychloroquine |
≥98% | | 询价 |
45 | | TNO155 HCl |
≥98% | | 询价 |
46 | | HBC599 |
≥98% | 50mg, 100mg, 250mg | 询价 |
47 | | HBC620 |
≥98% | 50mg, 100mg, 250mg | 询价 |
48 | 328076-61-5 | Ceranib1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
49 | 479413-68-8 | CUDA |
≥98% | | 询价 |
50 | 547-32-0 | Sulfadiazine sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
51 | 452967-14-5 | IR415 |
≥98% | | 询价 |
52 | 28270-04-4 | Glucagon HCl |
≥98% | | 询价 |
53 | 1228439-71-1 | (+)-KCC2 blocker 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
54 | 484006-66-8 | β-Glucuronidase-IN-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
55 | 14348-38-0 | 4-Bromo-3-hydroxybenzoic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
56 | 1789738-04-0 | AMY-101 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
57 | 77521-29-0 | (RS)-AMPA |
≥98% | 50mg, 100mg, 250mg | 询价 |
58 | 2408642-48-6 | FN-1501-propionic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
59 | 1310426-29-9 | SEP-363856 HCl |
≥98% | | 询价 |
60 | 2169919-21-3 | SNDX-5613 |
≥98% | | 询价 |